We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+6.12%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$556B
AUM Growth
+$22.5B
Cap. Flow
-$5B
Cap. Flow %
-0.9%
Top 10 Hldgs %
17.58%
Holding
2,638
New
69
Increased
1,185
Reduced
969
Closed
83

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$1.8B
2
TSLA icon
Tesla
TSLA
+$1.74B
3
NXPI icon
NXP Semiconductors
NXPI
+$1.24B
4
DHR icon
Danaher
DHR
+$1.21B
5
BKNG icon
Booking.com
BKNG
+$1.09B

Sector Composition

Rank Sector Weight
1 Healthcare 17.78%
2 Financials 16.36%
3 Consumer Discretionary 14.69%
4 Technology 14.23%
5 Industrials 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STWD icon
1501
Starwood Property Trust
STWD
$6.09B
$2.58M ﹤0.01%
114,985
+15,178
+15% +$339K
SVC
1502
Service Properties Trust
SVC
$1.06B
$2.57M ﹤0.01%
17,651
+1,158
+7% +$177K
ABMD
1503
DELISTED
Abiomed Inc
ABMD
$2.56M ﹤0.01%
17,884
-2,022
-10% -$272K
OLBK
1504
DELISTED
Old Line Bancshares, Inc.
OLBK
$2.52M ﹤0.01%
89,545
-23,978
-21% -$669K
CSOD
1505
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$2.51M ﹤0.01%
70,253
-1,944
-3% -$72.8K
RDY icon
1506
Dr. Reddy's Laboratories
RDY
$10.3B
$2.51M ﹤0.01%
297,775
OA
1507
DELISTED
Orbital ATK, Inc.
OA
$2.49M ﹤0.01%
25,293
-103,277
-80% -$10.2M
CHUBK
1508
DELISTED
CommerceHub, Inc. Series C Common Stock
CHUBK
$2.48M ﹤0.01%
142,113
+1,531
+1% +$25.3K
LAMR icon
1509
Lamar Advertising Co
LAMR
$15.6B
$2.46M ﹤0.01%
33,491
+90
+0.3% +$6.46K
DFT
1510
DELISTED
DuPont Fabros Technology Inc.
DFT
$2.45M ﹤0.01%
39,990
+344
+0.9% +$18.9K
RGA icon
1511
Reinsurance Group of America
RGA
$16.1B
$2.43M ﹤0.01%
18,950
-5
-0% -$631
DHC
1512
Diversified Healthcare Trust
DHC
$2.02B
$2.43M ﹤0.01%
118,728
-5,296
-4% -$113K
HZNP
1513
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.42M ﹤0.01%
203,918
-333,002
-62% -$4.14M
JBL icon
1514
Jabil
JBL
$38.4B
$2.41M ﹤0.01%
82,615
-39
-0% -$1.15K
CNI icon
1515
Canadian National Railway
CNI
$76.4B
$2.38M ﹤0.01%
29,429
+426
+1% +$32.5K
SPR
1516
DELISTED
Spirit AeroSystems
SPR
$2.37M ﹤0.01%
40,941
+16
+0% +$899
GBX icon
1517
The Greenbrier Companies
GBX
$1.41B
$2.36M ﹤0.01%
51,076
NNN icon
1518
NNN REIT
NNN
$8.79B
$2.35M ﹤0.01%
60,184
+8
+0% +$323
ICPT
1519
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2.34M ﹤0.01%
19,341
-974
-5% -$113K
TRN icon
1520
Trinity Industries
TRN
$2.3B
$2.32M ﹤0.01%
114,913
-6,554
-5% -$126K
THO icon
1521
Thor Industries
THO
$4.11B
$2.32M ﹤0.01%
22,179
+532
+2% +$51.5K
ARW icon
1522
Arrow Electronics
ARW
$10.7B
$2.31M ﹤0.01%
29,481
-1,014
-3% -$75.8K
LDOS icon
1523
Leidos
LDOS
$17.6B
$2.3M ﹤0.01%
44,546
+15
+0% +$799
WGL
1524
DELISTED
Wgl Holdings
WGL
$2.25M ﹤0.01%
26,969
+4
+0% +$332
ZBRA icon
1525
Zebra Technologies
ZBRA
$17.9B
$2.24M ﹤0.01%
22,325
-7
-0% -$693

Similar funds

T. Rowe Price Associates's Q2 2017 Portfolio in Review

As of Q2 2017, T. Rowe Price Associates held 2,638 positions worth $556B, up 4.2% from $534B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

T. Rowe Price Associates's Q2 2017 filing shows 69 new, 1,185 increased, 969 reduced and 83 closed positions. Its largest new stake was Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6: 15,513,011 shares worth $844M. The largest sale was Amazon, an estimated $1.8B.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2017 buy was Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6: 15,513,011 shares worth $844M.
  • T. Rowe Price Associates added most to Becton Dickinson in Q2 2017, an estimated $2.34B increase.
  • T. Rowe Price Associates's biggest Q2 2017 reduction was Amazon, cutting an estimated $1.8B.
  • T. Rowe Price Associates fully exited Yahoo Inc in Q2 2017, selling an estimated $362M.
  • T. Rowe Price Associates's ten largest holdings make up 18% of its $556B portfolio in Q2 2017.
  • T. Rowe Price Associates opened 69 new positions and closed 83 in Q2 2017.
  • T. Rowe Price Associates's portfolio value rose 4.2% quarter-over-quarter to $556B.

Based on T. Rowe Price Associates's 13F filing for Q2 2017, filed 14 Aug 2017.